Loading...

Gabriele Bergers, PhD

Title(s)Professor, Neurological Surgery
SchoolSchool of Medicine
AddressLocation Required
Varies CA 00000
Phone415-476-6786
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Research 
    Collapse Research Activities and Funding
    Inter-regulatory function of immune-modulation and angiogenesis in cancer
    NIH/NCI R01CA201537Aug 1, 2016 - Jul 31, 2021
    Role: Principal Investigator
    Autophagy as a microenvironmental regulator of tumorigenesis and resistance
    NIH/NCI R01CA188404Sep 1, 2014 - Aug 31, 2019
    Role: Co-Principal Investigator
    Biophysical and molecular dialogue of glioma cells and the brain microenvironment
    NIH/NCI U54CA163155Sep 26, 2011 - Jul 31, 2016
    Role: Principal Investigator
    Multipotential mesenchymal stem cell-like cells in pancreatic tumorigenesis
    NIH/NCI R01CA154383Apr 1, 2011 - Mar 31, 2016
    Role: Principal Investigator
    Perivascular Invasion of GBMs
    NIH/NCI R01CA113382Aug 15, 2006 - May 31, 2011
    Role: Principal Investigator
    PDGFRbeta+-Perivascular Cells In Tumor Angiogenesis
    NIH/NCI R01CA109390Aug 1, 2004 - May 31, 2009
    Role: Principal Investigator
    Mechanism and therapeutic targeting of evasive resistance to antiangiogenic drugs
    NIH/NCI R01CA099948Feb 11, 2003 - May 31, 2013
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Tumors vs. Chronic Wounds: An Immune Cell's Perspective. Front Immunol. 2019; 10:2178. Hua Y, Bergers G. PMID: 31572387.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    2. Peptide-guided nanoparticles for glioblastoma targeting. J Control Release. 2019 08 28; 308:109-118. Säälik P, Lingasamy P, Toome K, Mastandrea I, Rousso-Noori L, Tobi A, Simón-Gracia L, Hunt H, Paiste P, Kotamraju VR, Bergers G, Asser T, Rätsep T, Ruoslahti E, Bjerkvig R, Friedmann-Morvinski D, Teesalu T. PMID: 31255690.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    3. TMOD-03. GAINING A MECHANISTIC UNDERSTANDING OF THERAPY EVASION FROM DUAL MAPK PATHWAY INHIBITION IN A SYNGENEIC BRAFV600E MUTANT CDKN2A DELETED MOUSE MODEL TO PREEMPT RESISTANCE IN PATIENTS WITH BRAFV600E MUTANT PEDIATRIC GLIOMA. Neuro-Oncology. 2019 Apr 23; 21(Supplement_2):ii121-ii122. Wei Wang, Stefan Grossauer, Katharina Koeck, Erin Simonds, Edbert Lu, Gabriele Bergers, William Weiss, Claudia Petritsch. .
      View in: Publisher Site   Mentions:
    4. Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis. Annu Rev Physiol. 2019 02 10; 81:535-560. Mazzone M, Bergers G. PMID: 30742781.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    5. Where Have All the T Cells Gone? Immunity. 2018 10 16; 49(4):592-594. Vella G, Bergers G. PMID: 30332627.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    6. A tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma. Nat Cell Biol. 2018 10; 20(10):1203-1214. Barnes JM, Kaushik S, Bainer RO, Sa JK, Woods EC, Kai F, Przybyla L, Lee M, Lee HW, Tung JC, Maller O, Barrett AS, Lu KV, Lakins JN, Hansen KC, Obernier K, Alvarez-Buylla A, Bergers G, Phillips JJ, Nam DH, Bertozzi CR, Weaver VM. PMID: 30202050.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    7. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. 2018 08; 21(3):425-532. Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, Augustin HG, Bates DO, van Beijnum JR, Bender RHF, Bergers G, Bikfalvi A, Bischoff J, Böck BC, Brooks PC, Bussolino F, Cakir B, Carmeliet P, Castranova D, Cimpean AM, Cleaver O, Coukos G, Davis GE, De Palma M, Dimberg A, Dings RPM, Djonov V, Dudley AC, Dufton NP, Fendt SM, Ferrara N, Fruttiger M, Fukumura D, Ghesquière B, Gong Y, Griffin RJ, Harris AL, Hughes CCW, Hultgren NW, Iruela-Arispe ML, Irving M, Jain RK, Kalluri R, Kalucka J, Kerbel RS, Kitajewski J, Klaassen I, Kleinmann HK, Koolwijk P, Kuczynski E, Kwak BR, Marien K, Melero-Martin JM, Munn LL, Nicosia RF, Noel A, Nurro J, Olsson AK, Petrova TV, Pietras K, Pili R, Pollard JW, Post MJ, Quax PHA, Rabinovich GA, Raica M, Randi AM, Ribatti D, Ruegg C, Schlingemann RO, Schulte-Merker S, Smith LEH, Song JW, Stacker SA, Stalin J, Stratman AN, Van de Velde M, van Hinsbergh VWM, Vermeulen PB, Waltenberger J, Weinstein BM, Xin H, Yetkin-Arik B, Yla-Herttuala S, Yoder MC, Griffioen AW. PMID: 29766399.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansAnimals
    8. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer. Semin Cancer Biol. 2018 10; 52(Pt 2):107-116. Missiaen R, Mazzone M, Bergers G. PMID: 29935312.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    9. Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules. J Pathol. 2018 06; 245(2):209-221. He B, Jabouille A, Steri V, Johansson-Percival A, Michael IP, Kotamraju VR, Junckerstorff R, Nowak AK, Hamzah J, Lee G, Bergers G, Ganss R. PMID: 29603739.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    10. ANGI-12. IDENTIFICATION OF A NOVEL TYROSINE KINASE/INTEGRIN COMPLEX THAT DRIVES BRAIN METASTASES. Neuro-Oncology. 2017 Nov 6; 19(suppl_6):vi24-vi24. Arman Jahangiri, Maxim Sidorov, Alan Nguyen, Garima Yagnik, Sung Won Han, Smita Mascharak, Michael De Lay, Jeffrey Wagner, Brandyn Castro, Brandon Imber, Kan Lu, Gabriele Bergers, William Weiss, Manish K Aghi. .
      View in: Publisher Site   Mentions:
    11. Therapeutic induction of high endothelial venules (HEVs) to enhance T-cell infiltration in tumors. Oncotarget. 2017 Nov 21; 8(59):99207-99208. Allen E, Missiaen R, Bergers G. PMID: 29245888.
      View in: PubMed   Mentions:    Fields:    
    12. Cross-activating c-Met/ß1 integrin complex drives metastasis and invasive resistance in cancer. Proc Natl Acad Sci U S A. 2017 10 10; 114(41):E8685-E8694. Jahangiri A, Nguyen A, Chandra A, Sidorov MK, Yagnik G, Rick J, Han SW, Chen W, Flanigan PM, Schneidman-Duhovny D, Mascharak S, De Lay M, Imber B, Park CC, Matsumoto K, Lu K, Bergers G, Sali A, Weiss WA, Aghi MK. PMID: 28973887.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    13. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017 04 12; 9(385). Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, Feyen K, Tawney J, Hanahan D, Michael IP, Bergers G. PMID: 28404866.
      View in: PubMed   Mentions: 101     Fields:    Translation:AnimalsCells
    14. Trimming the Vascular Tree in Tumors: Metabolic and Immune Adaptations. Cold Spring Harb Symp Quant Biol. 2016; 81:21-29. Allen E, Missiaen R, Bergers G. PMID: 28396525.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    15. DRES-11. A CROSS-ACTIVATING c-Met/ß1 INTEGRIN COMPLEX DRIVES THERAPEUTIC RESISTANCE IN GLIOBLASTOMA. Neuro-Oncology. 2016 Nov 1; 18(suppl_6):vi53-vi54. Arman Jahangiri, Maxim Sidorov, Sung Won Han, William Chen, Jonathan Rick, Dina Schneidman-Duhovny, Smita Mascharak, Michael De Lay, Jeffrey Wagner, Brandyn Castro, Brandon Imber, Patrick Flanigan, Ruby Kuang, Kan Lu, Gabriele Bergers, Andrej Sali, William Weiss, Manish Aghi. .
      View in: Publisher Site   Mentions:
    16. Glioblastoma: Defining Tumor Niches. Trends Cancer. 2015 Dec; 1(4):252-265. Hambardzumyan D, Bergers G. PMID: 27088132.
      View in: PubMed   Mentions: 74     Fields:    
    17. CBIO-05UNDERSTANDING AND TACKLING PARACRINE SIGNALING CUES BETWEEN GLIOMA AND IMMUNE CELLS TO THWART GLIOMA INVASIVENESS AND ANGIOGENESIS. Neuro-Oncology. 2015 Nov 1; 17(suppl_5):v55-v56. Kan Lu, Dolores Hambardzumyan, Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    18. CANCER. Tumor angiogenesis, from foe to friend. Science. 2015 Aug 14; 349(6249):694-5. Rivera LB, Bergers G. PMID: 26273044.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    19. Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy. Cell Rep. 2015 Apr 28; 11(4):577-91. Rivera LB, Meyronet D, Hervieu V, Frederick MJ, Bergsland E, Bergers G. PMID: 25892230.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    20. Intertwined regulation of angiogenesis and immunity by myeloid cells. Trends Immunol. 2015 Apr; 36(4):240-9. Rivera LB, Bergers G. PMID: 25770923.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    21. HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer. NMR Biomed. 2014 Nov; 27(11):1361-70. Wang AS, Lodi A, Rivera LB, Izquierdo-Garcia JL, Firpo MA, Mulvihill SJ, Tempero MA, Bergers G, Ronen SM. PMID: 25199993.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    22. HIGH INTERSTITIAL FLUID PRESSURE REGULATES TUMOR GROWTH AND DRUG UPTAKE IN HUMAN GLIOBLASTOMA. Neuro-Oncology. 2014 Jul 1; 16(suppl_3):iii32-iii32. Anders I. Persson, Shirin Ilkhanizadeh, Yekaterina A. Miroshnikova, Aaron Frantz, John N. Lakins, C. David James, Tracy R. McKnight, Mitchel S. Berger, Gabriele Bergers, William A. Weiss, Valerie M. Weaver. .
      View in: Publisher Site   Mentions:
    23. UNDERSTANDING AND TACKLING THE TUMOR-IMMUNE CELL DIALOGUE DURING PROGRESSION AND THERAPEUTIC RESISTANCE. Neuro-Oncology. 2014 Jul 1; 16(suppl_3):iii16-iii16. Gabriele Bergers, Kan Lu, Lee Rivera. .
      View in: Publisher Site   Mentions:
    24. Angiogenesis. Targeting vascular sprouts. Science. 2014 Jun 27; 344(6191):1449-50. Rivera LB, Bergers G. PMID: 24970064.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    25. Novel target for peptide-based imaging and treatment of brain tumors. . 2014 Apr; 13(4):996-1007. Hyvönen M, Enbäck J, Huhtala T, Lammi J, Sihto H, Weisell J, Joensuu H, Rosenthal-Aizman K, El-Andaloussi S, Langel U, Närvänen A, Bergers G, Laakkonen P. PMID: 24493698.
      View in: PubMed   Mentions:
    26. Escape mechanisms from antiangiogenic therapy: an immune cell's perspective. Adv Exp Med Biol. 2014; 772:83-99. Rivera L, Pandika M, Bergers G. PMID: 24272355.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    27. Location, location, location: macrophage positioning within tumors determines pro- or antitumor activity. Cancer Cell. 2013 Dec 09; 24(6):687-9. Rivera LB, Bergers G. PMID: 24332035.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    28. Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance. Clin Cancer Res. 2013 Apr 01; 19(7):1773-83. Jahangiri A, De Lay M, Miller LM, Carbonell WS, Hu YL, Lu K, Tom MW, Paquette J, Tokuyasu TA, Tsao S, Marshall R, Perry A, Bjorgan KM, Chaumeil MM, Ronen SM, Bergers G, Aghi MK. PMID: 23307858.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansAnimalsCells
    29. Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma. CNS Oncol. 2013 Jan; 2(1):49-65. Lu KV, Bergers G. PMID: 23750318.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    30. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell. 2012 Jul 10; 22(1):21-35. Lu KV, Chang JP, Parachoniak CA, Pandika MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ, Cheresh DA, Park M, Bergers G. PMID: 22789536.
      View in: PubMed   Mentions: 222     Fields:    Translation:HumansCells
    31. Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell. 2011 Sep 13; 20(3):328-40. Sugiarto S, Persson AI, Munoz EG, Waldhuber M, Lamagna C, Andor N, Hanecker P, Ayers-Ringler J, Phillips J, Siu J, Lim DA, Vandenberg S, Stallcup W, Berger MS, Bergers G, Weiss WA, Petritsch C. PMID: 21907924.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansAnimalsCells
    32. Tumor microenvironment and progression. J Surg Oncol. 2011 May 01; 103(6):468-74. Dvorak HF, Weaver VM, Tlsty TD, Bergers G. PMID: 21480238.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    33. Non-stem cell origin for oligodendroglioma. Cancer Cell. 2010 Dec 14; 18(6):669-82. Persson AI, Petritsch C, Swartling FJ, Itsara M, Sim FJ, Auvergne R, Goldenberg DD, Vandenberg SR, Nguyen KN, Yakovenko S, Ayers-Ringler J, Nishiyama A, Stallcup WB, Berger MS, Bergers G, McKnight TR, Goldman SA, Weiss WA. PMID: 21156288.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansAnimalsCells
    34. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res. 2009 Sep 01; 69(17):6889-98. Lu KV, Zhu S, Cvrljevic A, Huang TT, Sarkaria S, Ahkavan D, Dang J, Dinca EB, Plaisier SB, Oderberg I, Lee Y, Chen Z, Caldwell JS, Xie Y, Loo JA, Seligson D, Chakravari A, Lee FY, Weinmann R, Cloughesy TF, Nelson SF, Bergers G, Graeber T, Furnari FB, James CD, Cavenee WK, Johns TG, Mischel PS. PMID: 19690143.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    35. Identifying Mechanisms of Bevacizumab Evasion in Human Glioblastoma. Neurosurgery. 2009 Aug 1; 65(2):424. Manish Kumar Aghi, Samuel D. Rose, Scott R. VandenBerg, Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    36. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009 Mar 03; 15(3):220-31. Pàez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Viñals F, Inoue M, Bergers G, Hanahan D, Casanovas O. PMID: 19249680.
      View in: PubMed   Mentions: 896     Fields:    Translation:HumansAnimals
    37. Bone Marrow-Derived Cells in GBM Neovascularization. CNS Cancer. 2009 Jan 1; 749-773. Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    38. Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer. 2008 Aug; 8(8):592-603. Bergers G, Hanahan D. PMID: 18650835.
      View in: PubMed   Mentions: 1026     Fields:    Translation:HumansCells
    39. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008 Jun 24; 6:14. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF, Bergers G, Weiss WA, Alvarez-Buylla A, Hodgson JG. PMID: 18577219.
      View in: PubMed   Mentions: 389     Fields:    Translation:HumansAnimalsCells
    40. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro Oncol. 2008 Jun; 10(3):254-64. Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G. PMID: 18359864.
      View in: PubMed   Mentions: 44     Fields:    Translation:Animals
    41. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008 Mar; 13(3):206-20. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z, Bergers G. PMID: 18328425.
      View in: PubMed   Mentions: 453     Fields:    Translation:AnimalsCells
    42. HIFa induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis. The FASEB Journal. 2008 Mar 1; 22:88.2-88.2. Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    43. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med. 2008 Jan 29; 5(1):e19. Pietras K, Pahler J, Bergers G, Hanahan D. PMID: 18232728.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansAnimalsCells
    44. Chapter 3. Bone marrow-derived vascular progenitors and proangiogenic monocytes in tumors. Methods Enzymol. 2008; 445:53-82. Lu K, Lamagna C, Bergers G. PMID: 19022055.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    45. Pericytes, the Mural Cells of the Microvascular System. Angiogenesis. 2008 Jan 1; 45-53. Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    46. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Res. 2007 Oct 01; 67(19):9435-42. Chesler L, Goldenberg DD, Seales IT, Satchi-Fainaro R, Grimmer M, Collins R, Struett C, Nguyen KN, Kim G, Tihan T, Bao Y, Brekken RA, Bergers G, Folkman J, Weiss WA. PMID: 17909053.
      View in: PubMed   Mentions: 24     Fields:    Translation:Animals
    47. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo. Cancer Res. 2006 Dec 01; 66(23):11331-40. Kawaguchi T, Yamashita Y, Kanamori M, Endersby R, Bankiewicz KS, Baker SJ, Bergers G, Pieper RO. PMID: 17145879.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    48. ID: 373 MMP-9-dependent regulation of angiogenesis and invasion in GBM. Journal of Thrombosis and Haemostasis. 2006 Oct 1; 4(s1):46-46. R. Du, C. Petritsch, H. Song, Z. Werb, G. Bergers. .
      View in: Publisher Site   Mentions:
    49. The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol. 2006 Oct; 80(4):677-81. Lamagna C, Bergers G. PMID: 16888086.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    50. Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents. Cancer Metastasis Rev. 2006 Jun; 25(2):243-52. Holash J, Thurston G, Rudge JS, Yancopoulos GD, Adjei AA, Bergers G, Pytowski B, Pegram M, Gordon MS. PMID: 16770536.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    51. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell. 2005 Oct; 8(4):299-309. Casanovas O, Hicklin DJ, Bergers G, Hanahan D. PMID: 16226705.
      View in: PubMed   Mentions: 541     Fields:    Translation:HumansCells
    52. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 2005 Oct; 7(4):452-64. Bergers G, Song S. PMID: 16212810.
      View in: PubMed   Mentions: 397     Fields:    Translation:HumansAnimalsCells
    53. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol. 2005 Sep; 7(9):870-9. Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G. PMID: 16113679.
      View in: PubMed   Mentions: 187     Fields:    Translation:AnimalsCells
    54. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization. Blood. 2005 Feb 01; 105(3):1094-101. Berger M, Bergers G, Arnold B, Hämmerling GJ, Ganss R. PMID: 15459006.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    55. Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme. Cancer Res. 2004 Apr 15; 64(8):2751-8. Kanamori M, Vanden Berg SR, Bergers G, Berger MS, Pieper RO. PMID: 15087390.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    56. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. Cancer Cell. 2003 Nov; 4(5):393-403. Joyce JA, Laakkonen P, Bernasconi M, Bergers G, Ruoslahti E, Hanahan D. PMID: 14667506.
      View in: PubMed   Mentions: 58     Fields:    Translation:AnimalsCells
    57. The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell. 2003 Aug; 4(2):133-46. Blouw B, Song H, Tihan T, Bosze J, Ferrara N, Gerber HP, Johnson RS, Bergers G. PMID: 12957288.
      View in: PubMed   Mentions: 139     Fields:    Translation:AnimalsCells
    58. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003 Jun; 3(6):401-10. Bergers G, Benjamin LE. PMID: 12778130.
      View in: PubMed   Mentions: 915     Fields:    Translation:HumansAnimals
    59. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003 May; 111(9):1287-95. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. PMID: 12727920.
      View in: PubMed   Mentions: 394     Fields:    Translation:AnimalsCells
    60. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water. Cancer Res. 2002 May 15; 62(10):2731-5. Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS. PMID: 12019144.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimalsCells
    61. Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice. Cold Spring Harb Symp Quant Biol. 2002; 67:293-300. Bergers G, Hanahan D. PMID: 12858552.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    62. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000 Oct; 2(10):737-44. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. PMID: 11025665.
      View in: PubMed   Mentions: 756     Fields:    Translation:AnimalsCells
    63. Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects. Expert Opinion on Therapeutic Targets. 2000 Oct 1; 4(5):609-633. Mark D Sternlicht, Gabriele Bergers. .
      View in: Publisher Site   Mentions:
    64. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice. J Clin Invest. 2000 Apr; 105(8):1045-7. Hanahan D, Bergers G, Bergsland E. PMID: 10772648.
      View in: PubMed   Mentions: 171     Fields:    Translation:HumansAnimalsCells
    65. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev. 2000 Feb; 10(1):120-7. Bergers G, Coussens LM. PMID: 10679388.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimals
    66. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999 Jun 01; 13(11):1382-97. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D. PMID: 10364156.
      View in: PubMed   Mentions: 263     Fields:    Translation:HumansAnimalsCells
    67. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 1999 Apr 30; 284(5415):808-12. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. PMID: 10221914.
      View in: PubMed   Mentions: 204     Fields:    Translation:Animals
    68. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998 May 01; 93(3):411-22. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. PMID: 9590175.
      View in: PubMed   Mentions: 424     Fields:    Translation:AnimalsCells
    69. Angiogenesis and apoptosis are cellular parameters of neoplastic progression in transgenic mouse models of tumorigenesis. Int J Dev Biol. 1998; 42(7):995-1002. Bergers G, Hanahan D, Coussens LM. PMID: 9853830.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    Gabriele's Networks
    Concepts (311)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (32)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑